About the speakers

Professor Peter Libby

Brigham and Women's Hospital, Boston (United States of America)
37 presentations
6 followers

Professor Erik Stroes

Academic Medical Centre, Amsterdam (Netherlands (The))
39 presentations
0 follower

Professor Philippe Gabriel Steg

Hospital Bichat-Claude Bernard, Paris (France)
65 presentations
10 followers

Doctor Pam Taub

University of California San Diego, La Jolla (United States of America)
5 presentations
0 follower

4 more presentations in this session

Introduction

Speaker: Professor P. Libby (Boston, US)

Thumbnail

Challenges in atherosclerotic cardiovascular disease reduction and triglyceride-related risk

Speaker: Professor E. Stroes (Amsterdam, NL)

Thumbnail

Perspectives on the results of recent clinical outcome trials with icosapent ethyl

Speaker: Professor P. Steg (Paris, FR)

Thumbnail

Integrating icosapent ethyl in cardiovascular risk reduction strategies: practical guidance

Speaker: Doctor P. Taub (La Jolla, US)

Thumbnail

Access the full session

Improving the management of patients with atherosclerotic cardiovascular disease: the evolving role of icosapent ethyl

Speakers: Professor P. Libby, Professor E. Stroes, Professor P. Steg, Doctor P. Taub, Professor P. Libby...
Thumbnail

About the event

Image

ESC Congress 2023

25 August - 28 August 2023

Sessions Presentations

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb